InvestorsHub Logo
Followers 0
Posts 88
Boards Moderated 0
Alias Born 07/15/2013

Re: Greeny1 post# 79102

Thursday, 07/18/2013 10:41:14 AM

Thursday, July 18, 2013 10:41:14 AM

Post# of 130516
It will more than triple. A positive analytical feedback for LymPro from BD will lead somebody (BD most likely) to conduct CLIA study. For CLIA study, BD will have to pay AMBS, most likely $500-800M. That is what Lilly paid for AmyVid, which is not even half as good as LymPro.


A positive analytical feedback for LymPro can catapult AMBS to 40-60X.